Munich Cluster for Systems Neurology
print


Breadcrumb Navigation


Content

TDP-43 and FUS en route from the nucleus to the cytoplasm

FEBS Lett. 2017 Apr 5. doi: 10.1002/1873-3468.12646. [Epub ahead of print]

Authors/Editors: Ederle H, Dormann D.
Publication Date: 2017

2017_04_ederle

Abstract

Misfolded or mislocalized RNA-binding proteins (RBPs) and, consequently, altered mRNA processing, can cause neuronal dysfunction, eventually leading to neurodegeneration. Two prominent examples are the RBPs TAR DNA-binding protein of 43 kDa (TDP-43) and fused in sarcoma (FUS), which form pathological messenger ribonucleoprotein aggregates in patients suffering from amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two devastating neurodegenerative disorders. Here, we review the multiple functions of TDP-43 and FUS in mRNA processing, both in the nucleus and in the cytoplasm. We discuss how TDP-43 and FUS may exit the nucleus and how defects in both nuclear and cytosolic mRNA processing events, and possibly nuclear export defects, may contribute to neurodegeneration and ALS/FTD pathogenesis.

Related Links